Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Antibody therapy

Human resistin is critical to activation of the NLRP3 inflammasome in macrophages

Udeshika Kariyawasam, Winson Lam, [ ... ], Roger A. Johns

Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study

Kazuma Nishisaka, Takaichi Okano, [ ... ], Jun Saegusa

Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis

Richard B. Warren, Hamish J. A. Hunter, [ ... ], Timothy T. Lu

Clinical characteristics, diagnostic modalities, and therapeutic strategies of spontaneous renal artery dissection: A systematic review and diagnostic analysis

Jiahao Zhu, Zengqiang Xu, [ ... ], Yingjiang Xu

Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV

Chunchun Liu, Yulei Ren, [ ... ], Huirong Yang

The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells

Meng Li, Yuwei Zhao, [ ... ], Xuemei Fu

Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies

Takuya Mizuno, Yukinari Kato, Toshihiro Tsukui, Masaya Igase

Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment

Lindsey E. Fish, Samantha C. Roberts, [ ... ], Adit A. Ginde

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Elizabeth S. Munroe, Greg A. Grandits, [ ... ], for the STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups

A human antibody specific for SIRPα reprograms macrophages and promotes antibody mediated anti-cancer activity

Keifer G. Kurtz, Irina Lebedeva, [ ... ], David A. Scheinberg

ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation

Jeong Eun Kang, Hyun Wook Seo, [ ... ], Cheol-Hee Yoon

CD38-targeted attenuated interferon alpha immunocytokine activates both innate and adaptive immune cells to drive anti-tumor activity

James F. Sampson, Hong Zhang, [ ... ], Michael Curley

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment – a sub-analysis of a randomized, cross-over bioequivalence trial

Vatsala Rajendram, Martyn Paddick, John More

Advertisement

Create a weekly email alert for: Antibody therapy

You can change these options by clicking profile then "Alerts and Notifications"